Third View Private Wealth, LLC Vertex Pharmaceuticals Inc Transaction History
Third View Private Wealth, LLC
- $743 Billion
- Q4 2025
A detailed history of Third View Private Wealth, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Third View Private Wealth, LLC holds 15,717 shares of VRTX stock, worth $6.82 Million. This represents 0.96% of its overall portfolio holdings.
Number of Shares
15,717Holding current value
$6.82 Million% of portfolio
0.96%Shares
1 transactions
Others Institutions Holding VRTX
# of Institutions
1,807Shares Held
231MCall Options Held
1.83MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA25.9MShares$11.2 Billion1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$10.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.25 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.6MShares$7.18 Billion1.27% of portfolio
-
State Street Corp Boston, MA11.6MShares$5.04 Billion0.16% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $111B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...